A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

5.2K views

⸱

DOI:

10.3791/62311

⸱

July 24th, 2021

 ,  , 

In This Article

Summary

This protocol describes how to study all possible combinations that can be obtained between four drugs in one single experiment. This method is based on the standard 96-well plate micro dilution assay and the calculation of fractional inhibitory concentrations (FICs) to evaluate the results.

Abstract

The concept of drug-combination therapy is becoming very important mainly with the drastic increase in resistance to drugs. The Quadruple checkerboard, also called the Q-checkerboard, aims at maximizing the number of possible combinations that can be obtained between four drugs in one experiment to minimize the time and work needed to accomplish the same results with other protocols. This protocol is based on the simple micro dilution technique where the drugs are diluted and combined together in several 96-well plates.

In the first set of 96-well plates, Muller-Hinton broth is added followed by the first required drug (e.g., Cefotaxime here) to serially dilute it. After the first step is done, another set of 96-well plates is used to dilute the second drug (e.g., Amikaci), which will be transferred by removing a specific volume of drug 2 and put in the corresponding wells in the first set of 96-well plates that contains drug one. The third step is done by adding the required concentrations of the third drug (e.g., Levofloxacin), to the appropriate plates in the initial set containing combination of drug 1 and 2. The fourth step is done by adding the required concentrations of the fourth drug (e.g., Trimethoprim-sulfamethoxazol) into the appropriate plates in the first set. Then, E. coli ESBL bacterial inoculum will be prepared and added.

This method is important to evaluate all the possible combinations and has a wider range of possibilities to be tested furthermore for in vivo testing. Despite being a tiring technique requiring a lot of focus, the results are remarkable and time saving where a lot of combinations can be tested in a single experiment.

Introduction

With the increase in resistance due to the overuse and misuse of antibiotics1,2, the need to develop new drugs and agents to treat bacterial infections has become crucial. New approaches such as developing new drugs are very important to overcome the resistance crisis. However, the pharmaceutical industry is not interested in developing new antimicrobial agents. Moreover, if new drugs are developed, bacteria will keep on evolving and developing resistance against these new drugs3,4. Thus, the problem of resistance will not be solved, making the need fo....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Preparation steps

  1. Prepare Muller-Hinton broth (MHB) by adding 25 g of MH broth to 1 L of distilled water and mix. Autoclave at 121 °C for 2.5 h. Then, store the autoclaved media at room temperature or in the fridge.
  2. Subculture the bacteria in question (E. coli ESBL) on the agar media using the four-quadrant streaking method and incubate overnight at 37 °C.
    1. Using a sterile loop, take one colony and spread it in the first half of the MacConkey agar plate by doing close parallel streaks.
    2. Using the loop, spread the bacteria in the second quadrant by streaking it from the first quadrant.
    3. From the....

Access restricted. Please log in or start a trial to view this content.

Results

Figure 2A represents the results obtained by combining Cefotaxime and Amikacin with specific concentrations of Levofloxacin and Trimethoprim-sulfamethoxazole. We can see in the left part of the figure the four plates that are schematically presented with the concentrations of the drugs in the right part of the figure. The arrows represent the wells on the Growth/no Growth interface. The colored wells are the wells that contain growth. We notice that the fourth plate does not contain growth i.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The Quadruple Checkerboard method resembles the checkerboard and the three dimensional checkerboard in its protocol. However, certain crucial steps should be taken into consideration to avoid errors during the experiment.

Make sure to test for the MIC of each drug against the tested isolate before starting the protocol to know what are the concentrations that are needed to start the dilutions with for drug 1 and drug 2 that need to be serially diluted in the plates. Concerning drug 3 and .......

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
1000 µL tipsCitotest4330000402
200 µL tipsCitotest4330-0013-17
50 mL centrifuge tubecorning430828For drug 3 and 4 preparation
5 mL polysterene round-bottom TubeFalcon352058For 0.5 MacFarland bacterial inoculum preparation
90mm petri dishesJRZ PlastilabAs bed for the solutions to be added using the multichannel pipette
96-well platescorning3596For serial diltuion and combining drugs
Bactrim 200, 40 mg (Trimethoprim-sulamethoxazoleBy CRNEXI SAS Fontenay-sous-Bois, France10177403Drug 4
Ceforane, 1 g (Cefotaxime)PHARCO Pharmaceuticals24750/2006Drug 1
Densitometer
E. Coli ESBL strainRetreived as a medical strain from the Saint-George Hospital LebanonBacterial strain
Mac Conkey + crystal violet agarBIO-RAD64169508For making agar plates used for subculturing
Miacin 500 mg/2 mL (Amikacin)HIKMA Pharmaceuticals2BXMIA56N-AEFDrug 2
Muller-Hinton BrothBIO-RAD69444For making bacterial media
Multichannel PipetteThermo ScientificGJ54761For serial dilution and addition of media, bacteria and drugs
Paper Tape
Single Channel pipettesThermo ScientificOH19855 HH40868For the addition of media, bacteria and drugs
Tavanic, 500 mg (Levofloxacin)sanofi aventis221937/2009Drug 3

References

  1. Ibezim, E. Microbial resistance to antibiotics. African Journal of Biotechnology. 4, 1606-1611 (2006).
  2. Ventola, C. L. The antibiotic resistance crisis: part 1: causes and threats. P & T: A Peer-Reviewed Journal for Formulary Management. <....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Drug Combination TherapyMulti-Drug ResistanceMicrodilution Technique96-Well PlatesAntimicrobial CombinationsSerial DilutionBacterial InoculumMuller-Hinton BrothMIC Determination